Circulation, Vol 88, 1569-1578, Copyright © 1993 by American Heart Association
JJ Popma, LF Satler, AD Pichard, KM Kent, A Campbell, YC Chuang, C Clark, AJ Merritt, TA Bucher and MB Leon
BACKGROUND. Despite their potential advantages, new coronary angioplasty
devices may be associated with more frequent vascular complications than
noted after standard balloon angioplasty, theoretically due to the larger
sheaths and prolonged periods of anticoagulation required by some of these
devices. This study sought to identify the incidence, predictors, and
clinical outcome of vascular complications after new device angioplasty.
METHODS AND RESULTS. The clinical course of 1413 patients was reviewed
after balloon or new device angioplasty. Vascular complications were
defined as formation of a pseudoaneurysm, arteriovenous fistula,
retroperitoneal hematoma, or groin hematoma associated with a > 15-point
hematocrit drop or the need for surgical repair. Stepwise logistic
regression was used to identify independent predictors for vascular
complications. Vascular complications developed after 84 (5.9%) procedures;
they occurred more frequently after intracoronary stenting (14.0%) and
extraction atherectomy (12.5%) than after balloon angioplasty (3.2%) (odds
ratios, 4.86; P < .001, and 4.26, P < .05, respectively). Independent
predictors of vascular complications included the use of intraprocedural
thrombolytic agents (P < .01), intracoronary stenting (P < .005), or
extraction atherectomy (P < .05); high maximum creatinine level (P <
.005); low nadir platelet count (P < .001); longer periods of excess
anticoagulation (P < .05); and the need for repeat coronary angioplasty
(P < .005). Vascular complications were not related to the size of the
arterial sheath used. CONCLUSIONS. Vascular complications developed more
frequently after new device angioplasty than after balloon angioplasty,
with the risk for vascular complications directly related to the degree of
periprocedural anticoagulation.
ARTICLES
Vascular complications after balloon and new device angioplasty
Department of Internal Medicine Cardiology Division, Washington Hospital Center, Washington, DC 20010.
This article has been cited by other articles:
![]() |
S. B. Joshi, D. D. Mendoza, D. H. Steinberg, M. A. Goldstein, C. F. Lopez, A. Raizon, G. Weissman, L. F. Satler, A. D. Pichard, and Wm. G. Weigold Ultra-Low-Dose Intra-Arterial Contrast Injection for Iliofemoral Computed Tomographic Angiography J. Am. Coll. Cardiol. Img., December 1, 2009; 2(12): 1404 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mlekusch, E. Minar, P. Dick, S. Sabeti, A. Bartok, M. Haumer, M. Bonelli, L. Vormittag, R. Koppensteiner, and M. Schillinger Access Site Management after Peripheral Percutaneous Transluminal Procedures: Neptune Pad Compared with Conventional Manual Compression Radiology, December 1, 2008; 249(3): 1058 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Webber, J. Jang, S. Gustavson, and J. W. Olin Contemporary Management of Postcatheterization Pseudoaneurysms Circulation, May 22, 2007; 115(20): 2666 - 2674. [Full Text] [PDF] |
||||
![]() |
W. Mlekusch, M. Haumer, I. Mlekusch, P. Dick, S. Steiner-Boeker, A. Bartok, S. Sabeti, M. Exner, O. Wagner, E. Minar, et al. Prediction of iatrogenic pseudoaneurysm after percutaneous endovascular procedures. Radiology, August 1, 2006; 240(2): 597 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Hamner, E. J. Dubois, and T. P. Rice Predictors of Complications Associated With Closure Devices After Transfemoral Percutaneous Coronary Procedures Crit. Care Nurse, June 1, 2005; 25(3): 30 - 37. [Full Text] [PDF] |
||||
![]() |
K. Khaghany, F. Al-Ali, T. Spigelmoyer, R. Pimentel, and K. Wharton Efficacy and Safety of the Perclose Closer S Device After Neurointerventional Procedures: Prospective Study and Literature Review AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1420 - 1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.M. O. Farouque, J. A. Tremmel, F. R. Shabari, M. Aggarwal, W. F. Fearon, M. K.C. Ng, M. Rezaee, A. C. Yeung, and D. P. Lee Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices J. Am. Coll. Cardiol., February 1, 2005; 45(3): 363 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moscucci, K.A.A. Fox, C. P. Cannon, W. Klein, J. Lopez-Sendon, G. Montalescot, K. White, R.J. Goldberg, and for the GRACE Investigators Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur. Heart J., October 2, 2003; 24(20): 1815 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Funovics, F. Wolf, M. O. Philipp, S. Kee, B. Tichy, A. Dirisamer, T. Rand, and J. Lammer Feasibility Study of NeoMend, a Percutaneous Arterial Closure Device That Uses a Nonthrombogenic Bioadhesive Am. J. Roentgenol., February 1, 2003; 180(2): 533 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kelm, S. M. Perings, T. Jax, T. Lauer, F. C. Schoebel, M. P. Heintzen, C. Perings, and B. E. Strauer Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas: Implications for risk stratification and treatment J. Am. Coll. Cardiol., July 17, 2002; 40(2): 291 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Applegate, M. A. Grabarczyk, W. C. Little, T. Craven, M. Walkup, F. R. Kahl, G. A. Braden, K. M. Rankin, and M. A. Kutcher Vascular closure devices in patients treated with anticoagulation and iib/iiia receptor inhibitors during percutaneous revascularization J. Am. Coll. Cardiol., July 3, 2002; 40(1): 78 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mueller, G. Buerkle, H. J. Buettner, J. Petersen, A. P. Perruchoud, U. Eriksson, S. Marsch, and H. Roskamm Prevention of Contrast Media-Associated Nephropathy: Randomized Comparison of 2 Hydration Regimens in 1620 Patients Undergoing Coronary Angioplasty Arch Intern Med, February 11, 2002; 162(3): 329 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Smith Jr, J. T. Dove, A. K. Jacobs, J. Ward Kennedy, D. Kereiakes, M. J. Kern, R. E. Kuntz, J. J. Popma, H. V. Schaff, D. O. Williams, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2239 - 2239. [Full Text] [PDF] |
||||
![]() |
J. J. Popma, E. M. Ohman, J. Weitz, A. M. Lincoff, R. A. Harrington, and P. Berger Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention Chest, January 1, 2001; 119 (2009): 321S - 336S. [Full Text] [PDF] |
||||
![]() |
R Choussat, A Black, I Bossi, J Fajadet, and J Marco Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade. Comparison of transradial vs transfemoral arterial access Eur. Heart J., April 2, 2000; 21(8): 662 - 667. [Abstract] [PDF] |
||||
![]() |
M. Rabah, D. Mason, D. W. M. Muller, R. Hundley, A. D. Kugelmass, B. Weiner, L. Cannon, W. W. O'Neill, and R. D. Safian Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention J. Am. Coll. Cardiol., August 1, 1999; 34(2): 461 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Salachas, S. P. Patsilinakos, K. P. Tsilias, I. Stefanou, N. G. Margaris, G. P. Ifantis, A. J. Kranidis, A. G. Tavernarakis, S. G. Rokas, and I. Antonellis Elective Intracoronary Micro-Stent IITM Implantation Without Quantitative Coronary Angiography or Intravascular Ultrasound Guidance and Without Subsequent Anticoagulation: Short- and Long-Term Results Angiology, May 1, 1999; 50(5): 381 - 391. [Abstract] [PDF] |
||||
![]() |
K T Koch, J J Piek, R J de Winter, K Mulder, C E Schotborgh, J G P Tijssen, and K I Lie Two hour ambulation after coronary angioplasty and stenting with 6 F guiding catheters and low dose heparin Heart, January 1, 1999; 81(1): 53 - 56. [Abstract] [Full Text] |
||||
![]() |
T. Mann, G. Cubeddu, J. Bowen, J. E. Schneider, M. Arrowood, W. N. Newman, M. J. Zellinger, and G. C. Rose Stenting in acute coronary syndromes: a comparison of radial versus femoral access sites J. Am. Coll. Cardiol., September 1, 1998; 32(3): 572 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Van Belle, C. Bauters, T. Asahara, and J. M. Isner Endothelial regrowth after arterial injury: from vascular repair to therapeutics Cardiovasc Res, April 1, 1998; 38(1): 54 - 68. [Full Text] [PDF] |
||||
![]() |
A. D. Kugelmass and G. E. Raskob Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty or Coronary Stent Placement Clinical and Applied Thrombosis/Hemostasis, October 1, 1997; 3(1_suppl): S24 - S31. [PDF] |
||||
![]() |
R. Zahn, E. Fromm, S. Thoma, R. Lotter, M. Zander, S. Wagner, K. Seidl, and J. Senges Local Venous Thrombosis After Cardiac Catheterization Angiology, January 1, 1997; 48(1): 1 - 7. [Abstract] [PDF] |
||||
![]() |
N. G Uren and N. A. Chronos Intracoronary stents BMJ, October 12, 1996; 313(7062): 892 - 893. [Full Text] |
||||
![]() |
G. J. Karrillon, M. C. Morice, E. Benveniste, P. Bunouf, P. Aubry, S. Cattan, B. Chevalier, P. Commeau, A. Cribier, C. Eiferman, et al. Intracoronary Stent Implantation Without Ultrasound Guidance and With Replacement of Conventional Anticoagulation by Antiplatelet Therapy: 30-Day Clinical Outcome of the French Multicenter Registry Circulation, October 1, 1996; 94(7): 1519 - 1527. [Abstract] [Full Text] |
||||
![]() |
S. G. Ellis, D. P. Miller, K. J. Brown, N. Omoigui, G. L. Howell, M. Kutner, and E. J. Topol In-Hospital Cost of Percutaneous Coronary Revascularization : Critical Determinants and Implications Circulation, August 15, 1995; 92(4): 741 - 747. [Abstract] [Full Text] |
||||
![]() |
S. C. Wong, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, G. S. Mintz, Y. C. Chuang, M. K. Hong, C. J. Ditrano, and M. B. Leon Comparison of Clinical and Angiographic Outcomes After Saphenous Vein Graft Angioplasty Using Coronary Versus `Biliary' Tubular Slotted Stents Circulation, January 15, 1995; 91(2): 339 - 350. [Abstract] [Full Text] |
||||
![]() |
NEW ANGIOPLASTY DEVICES HAVE A DOWN SIDE Journal Watch (General), October 26, 1993; 1993(1026): 5 - 5. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |